Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Perrigo adds cherry-flavored cetirizine

This article was originally published in The Tan Sheet

Executive Summary

FDA approves the private labeler's application to manufacture and market Cetirizine Cherry Syrup, 1 mg/mL - equivalent to Johnson & Johnson/McNeil's Zyrtec Children's Allergy Syrup. Perrigo's store-brand antihistamine will begin shipping to retailers by September, joining its current grape-flavored cetirizine syrup, Perrigo said July 26. The FDA approval is a good sign for Perrigo, as the application originated from the firm's Allegan, Mich., plant that elicited a warning letter in April due to quality system failings, Collins Stewart analyst Louise Chen said in a same-day note (1"The Tan Sheet" June 21, 2010). "We think that the FDA would not have approved a product out of Michigan if the agency felt there were substantive manufacturing issues at the facility," Chen wrote

You may also be interested in...

Perrigo Targets October For Quality System Corrections, FDA Re-Inspection

Perrigo wants FDA to re-inspect its Allegan, Mich., manufacturing plant in October, when the private labeler intends to have corrected its quality system failings that elicited a warning letter in April

Neuroscience Challenges Oncology For Top Spot In CDER’s 2019 Novel Approvals

Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.

In Case You Missed It … News On China Patents, EMA Chief, And More

We clean out your Martin Luther King Day inbox so you don't have to.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts